Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for O08750

Entry ID Method Resolution Chain Position Source
AF-O08750-F1 Predicted AlphaFoldDB

29 variants for O08750

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389285626 22 S>P No EVA
rs257828666 42 G>S No EVA
rs3389279321 52 M>I No EVA
rs3389277009 72 K>I No EVA
rs3389241583 98 D>E No EVA
rs3389291498 107 A>V No EVA
rs3389291492 123 K>I No EVA
rs3389277089 145 T>I No EVA
rs224450921 157 A>S No EVA
rs3389281581 184 Q>R No EVA
rs3389291517 202 S>I No EVA
rs3389298907 215 F>Y No EVA
rs3389282439 224 E>K No EVA
rs3404193716 230 R>M* No EVA
rs250632346 238 T>A No EVA
rs250632346 238 T>P No EVA
rs3389258321 303 V>L No EVA
rs864282659 310 A>S No EVA
rs3389291446 342 D>G No EVA
rs249589983 356 D>E No EVA
rs230622856 357 A>T No EVA
rs3389279310 384 Q>* No EVA
rs3389284338 393 L>F No EVA
rs3389211120 410 S>I No EVA
rs260898871 421 G>S No EVA
rs3389285388 435 Q>* No EVA
rs242052781 437 I>M No EVA
rs3389277073 445 V>I No EVA
rs3389284357 448 K>N No EVA

No associated diseases with O08750

2 regional properties for O08750

Type Name Position InterPro Accession
binding_site IQ motif, EF-hand binding site 209 - 235 IPR000048
domain ATPase, AAA-type, core 571 - 685 IPR003959

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
RNA polymerase II transcription regulator complex A transcription factor complex that acts at a regulatory region of a gene transcribed by RNA polymerase II.

5 GO annotations of molecular function

Name Definition
DNA-binding transcription factor activity A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
DNA-binding transcription repressor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that represses or decreases the transcription of specific gene sets transcribed by RNA polymerase II.
identical protein binding Binding to an identical protein or proteins.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.
RNA polymerase II transcription regulatory region sequence-specific DNA binding Binding to a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.

10 GO annotations of biological process

Name Definition
cellular response to interleukin-4 Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-4 stimulus.
circadian rhythm Any biological process in an organism that recurs with a regularity of approximately 24 hours.
immune response Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
natural killer cell differentiation The process in which a relatively unspecialized cell acquires the specialized features of a natural killer cell.
negative regulation of DNA-templated transcription Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
positive regulation of DNA-templated transcription Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
positive regulation of gene expression Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
regulation of DNA-templated transcription Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
transcription by RNA polymerase II The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).

6 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q90Z72 NFIL3 Nuclear factor interleukin-3-regulated protein Gallus gallus (Chicken) PR
P17676 CEBPB CCAAT/enhancer-binding protein beta Homo sapiens (Human) EV
Q16649 NFIL3 Nuclear factor interleukin-3-regulated protein Homo sapiens (Human) PR
P28033 Cebpb CCAAT/enhancer-binding protein beta Mus musculus (Mouse) SS
P21272 Cebpb CCAAT/enhancer-binding protein beta Rattus norvegicus (Rat) SS
Q6IMZ0 Nfil3 Nuclear factor interleukin-3-regulated protein Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MQLRKMQTIK KEPAPLDPTS SSDKMLLLNS ALAEVAEDLA SGEDLLLNEG SMGKNKSSAC
70 80 90 100 110 120
RRKREFIPDE KKDAMYWEKR RKNNEAAKRS REKRRLNDLV LENKLIALGE ENATLKAELL
130 140 150 160 170 180
SLKLKFGLIS STAYAQEIQK LSNSTAVYFQ DYQTSKAAVS SFVDEHEPAM VAGSCISVIK
190 200 210 220 230 240
HSPQSSLSDV SEVSSVEHTQ ESPAQGGCRS PENKFPVIKQ EPVELESFAR EAREERGTYS
250 260 270 280 290 300
TSIYQSYMGS SFSTYSHSPP LLQVHGSTSN SPRTSEADEG VVGKSSDGED EQQVPKGPIH
310 320 330 340 350 360
SPVELQRVHA TVVKVPEVNP SALPHKLRIK AKAMQVKVEA LDSEFEGMQK LSSPADAIAK
370 380 390 400 410 420
RHFDLEKHGT SGMAHSSLPP FSVQVTNIQD WSLKSEHWHH KELSSKTQSS FKTGVVEVKD
430 440 450 460
GGYKVSEAEN LYLKQGIANL SAEVVSLKRF IATQPISASD SR